SPR no: 09Z924639H
MRN no: 099924
Site_name: JOYCE PALMER HEALTH SERVICE
Facility_id: MR
Specimen_type: Fresh Tissue
Pathology Report09Z92463 (09Z924639H) Faddis, SPENCER
HISTOPATHOLOGY REPORT
PETER MACCALLUM CANCER CENTRE HOSPITAL LABORATORIES

CLINICAL NOTES:
L breast Ca 1 o&amp;apos;clock.
Frozen section. Left sentinel lymph node.
(1) L breast wide local excision
(2) L axillary clearance.

MACROSCOPIC:
A. &amp;quot;LEFT SENTINEL NODE&amp;quot;.  A blue node, 15mm in diameter.

F/S: &amp;quot;Metastatic carcinoma 3.5mm in diameter&amp;quot; per phone to Dr. Nyininy at 3:10pm on 04/02/72 by Dr. B. Streicher.

(1 frozen section; 2 remainder).

B.
Specimen labelled &amp;quot; WIDE LOCAL EXCISION LEFT BREAST&amp;quot;.
SPECIMEN SIDE: Left
SPECIMEN TYPE:  Wide local excision
SPECIMEN X-RAY:  Yes
HOOKWIRE:  Yes - hookwire split is located at E7 and is inked blue.
SPECIMEN DIMENSIONS:
Medial to lateral:  65mm
Superior to inferior:  50mm
Anterior to posterior:  25mm
WEIGHT:  36g
SKIN:  No
NIPPLE:  No
MUSCLE:  No
MARGIN INKED:  Standard: Anterior blue, Posterior black, Superior red, Inferior green.
DISSECTION: Cut from lateral to medial
Number of slices: 10
FINDINGS / LESION:  Area marked is located in Slice 6. Within Slices 5 and 6, there is fairly circumscribed firm creamy lesion, measuring 10mm medial to lateral, 13mm superior to inferior and 10mm anterior to posterior. Adjacent to this lesion, there is a fibrotic area which abuts posterior margin.
Tumour is 5mm from posterior margin, 7mm from anterior margin, 12mm from superior, 17mm from inferior and more than 18mm from the rest of margins.
(1 LS from Slice 1; 2 and 3 Slice 2; 4 portion of Slice 4; 5 and 6 Slice 5; 7 and 8 Slice 6; 9 and 10 Slice 7; 11 portion of Slice 8; 12 portion of Slice 9; 13 LS Slice 10). RS (M-13)
C. &amp;quot;LEFT AXILLARY CLEARANCE&amp;quot;. Fibrofatty tissue, 120x90x30mm. It contains multiple lymph nodes with a maximum dimension of 20mm.
(1 and 2 one lymph node, sliced; 3 one lymph node; 4 one lymph node bisected; 5 one lymph node; 6 one lymph node bisected; 7 one lymph node bisected; 8 ?four lymph nodes; 9 ?four lymph nodes). RS (M-9/SM 7/1/2071 cy)
MICROSCOPIC:  (Dr. B. Ferandez)

INVASIVE BREAST CANCER SYNOPTIC REPORT (Based on CAP 2017)
&amp;#160;
INVASIVE CARCINOMA:
&amp;#160;
NUMBER OF INVASIVE FOCI:  One
&amp;#160;
MAXIMUM INVASIVE TUMOUR SIZE: &amp;#160;19mm (in 3 consecutive slices).
&amp;#160;
INVASIVE CARCINOMA TYPE:  Infiltrating duct carcinoma.
&amp;#160;
HISTOLOGIC GRADE:  2

SCORES Tubules:  2, Nuclei:  2, Mitoses:  2; Total score: &amp;#160;6&amp;#160;(of 9)

MITOTIC RATE: &amp;#160;9&amp;#160;mitoses per 10 high power fields
&amp;#160;
WHOLE TUMOUR SIZE (INVASIVE + DCIS):  29mm
&amp;#160;
PERITUMOURAL LYMPHOVASCULAR INVASION:  Not seen
&amp;#160;
PERINEURAL INVASION:  Not seen
&amp;#160;
SKIN INVOLVEMENT:  Not applicable

DERMAL LYMPHOVASCULAR INVASION:  Not applicable
&amp;#160;
NIPPLE INVOLVEMENT:  Not applicable
&amp;#160;
MUSCLE INVOLVEMENT:  Not applicable
&amp;#160;
DUCTAL CARCINOMA IN SITU (DCIS): &amp;#160;
DCIS size / extent:  Extends 10mm beyond invasive tumour.
Nuclear grade:  Intermediate and high grade.
Architecture / type:  Solid/cribriform
Necrosis:  Present
Microcalcification of DCIS:  Absent
Extensive intraduct component:  Negative

LOBULAR CARCINOMA IN SITU (LCIS): &amp;#160;Not seen

EXCISION MARGINS
INVASIVE TUMOUR MARGINS:
Invasive carcinoma is completely excised with a clearance of 5mm from closest anterior and posterior margins.
&amp;#160;
DCIS MARGINS:
DCIS extends within 0.2mm of posterior margin without intervening normal ducts.
All other margins are clear of DCIS.
&amp;#160;
ANCILLARY TESTS:
IMMUNOSTAINS, block B5

HORMONE RECEPTORS (IMMUNOPEROXIDASE TECHNIQUE)
OESTROGEN RECEPTOR:         negative
PROGESTERONE RECEPTOR: negative

HER-2 IMMUNOPEROXIDASE
POSITIVE (score 3+) Her-2 SISH to follow

Ki-67 proliferative index:&amp;#160;40%
&amp;#160;
LYMPH NODES
SENTINEL LYMPH NODES&amp;amp;AXILLARY LYMPH NODES:  Involved by metastatic carcinoma.

Nodes with macrometastases: 6 (1 sentinel and 5 axillary).
Nodes with micrometastases:  1 (axillary)
Nodes with isolated tumor cells:  0
Total number of nodes examined:  12 (1 sentinel and 11 axillary).
&amp;#160;
Largest nodal tumour deposit:  8mm
Extranodal extension: &amp;#160;Present with a span of 2mm

PATHOLOGIC STAGE CLASSIFICATION (AJCC, TNM 8th edition):  pT1c, pN2a

DIAGNOSIS:
LEFT SENTINEL NODE:
- METASTATIC CARCINOMA IN 1 LYMPH NODE.
WIDE LOCAL EXCISION LEFT BREAST:
- INFILTRATING DUCT CARCINOMA.
LEFT AXILLARY CLEARANCE:
- METASTATIC CARCINOMA IN 6 OUT OF 11 LYMPH NODES.
8/1/2072 km
HER-2 IN-SITU HYBRIDISATION

Signal Detection has been performed for the HER2 gene (17q21) and chromosome 17 centromeric enumeration probe (CEP17) control using the Ventana INFORM HER2 Dual ISH DNA Probe Cocktail Assay (Roche).

Mean HER2 copy number per cell:  14.3
Mean CEP17 copy number per cell: 1.5
HER2/CEP17 Ratio: 9.5

HER2 status:          POSITIVE

SCORING CRITERIA:
Updated in line with ASCO/CAP recommendations 2018, see JCO 2018 36: 2105-2122):

Reported by: Dr B Sink
Date: 9.1.72
